BioMarin Pharmaceutical Inc. (BMRN) ownership: insiders 1% · institutions 99% (13F 2026-03-31). Insider activity, 90 days: 0 sales, 0 open-market buys. 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 19818301.00 | $1.12B | 10.2% | 2026-03-31 |
| Vanguard | 18465903.00 | $1.04B | 9.5% | 2026-03-31 |
| Dodge & Cox | 14561759.00 | $822.59M | 7.5% | 2026-03-31 |
| Primecap Management Co | 14194005.00 | $801.82M | 7.3% | 2026-03-31 |
| AQR Capital Management | 7676541.00 | $429.35M | 4.0% | 2026-03-31 |
| State Street | 7295079.00 | $412.10M | 3.8% | 2026-03-31 |
| Viking Global Investors LP | 7062077.00 | $398.94M | 3.6% | 2026-03-31 |
| Citadel | 4512634.00 | $254.92M | 2.3% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 |
Back to BMRN overview · BMRN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.